LexaGene Holdings Inc (OTCQB:LXXGF) (CVE:LXG) (FRA:5XS2) announced that Denver Animal Emergency (DAE) has ordered one of the company’s MiQLab diagnostics test systems.
“We have been using LexaGene’s MiQLab for several months as part of their early access program,” DAE Medical Director Andrew Pierce said in a statement. “We’ve compared the accuracy of the MiQLab to results generated by culture and there was such high concordance, we have found that we are running MiQLab more often than we are sending samples out for culture.”
MiQLab delivers excellent sensitivity, specificity, and breadth of detection, can test for 27 pathogens and returns results in about one hour versus 1-3 days at a lab, the company said.
READ: LexaGene Holdings in partnership to develop new diagnostics tests for companion animals
“The MiQLab identifies not just the most common pathogens, but also many common antimicrobial resistance factors,” Pierce said. “Knowing this information soon after seeing the animal has boosted our confidence that our prescribed therapies will effectively treat the infection, even if it is found to be resistant to some antibiotics. Our veterinarians have enjoyed using it so much, and our clients are benefiting with better care, so it was an easy decision to purchase the system.”
CEO Jack Regan commented on Pierce’s order, saying: “I’m pleased that Dr. Pierce and his team at Denver Animal Emergency has decided to purchase the MiQLab System. Dr. Pierce is sending a strong message to his patients that the benefits of point-of-care diagnostics, time to result and high concordance will lead to improved animal care and better medical outcomes for our companion animals. This is exactly why LexaGene is in veterinary health and why we aim to change the way veterinary diagnostics are done.”
The company also said it is ramping up sales efforts.
“I’m excited to report that our newly hired veterinary, sales representatives are pursuing many promising leads throughout their territories,” Regan said. “Their enthusiasm continues to grow as veterinarians are expressing their desire for in-hospital diagnostics. We look forward to announcing more veterinary sales soon.”
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel